{"id":5117,"date":"2021-03-23T10:48:06","date_gmt":"2021-03-23T09:48:06","guid":{"rendered":"http:\/\/websrv.saske.sk\/uef\/?page_id=5117"},"modified":"2025-06-09T10:22:30","modified_gmt":"2025-06-09T08:22:30","slug":"nanovir","status":"publish","type":"page","link":"https:\/\/websrv.saske.sk\/uef\/veda-a-vyskum\/projekty-v-ramci-opvai\/nanovir\/","title":{"rendered":"NANOVIR"},"content":{"rendered":"

<\/p>\n

Inform\u00e1cie o Opera\u010dnom programe Integrovan\u00e1 infra\u0161trukt\u00fara 2014 \u2013 2020 n\u00e1jdete na www.opii.gov.sk<\/a><\/p>\n

Nano\u010dastice pre rie\u0161enie diagnosticko-terapeutick\u00fdch probl\u00e9mov s COVID-19 (NANOVIR)<\/strong><\/h2>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
E\u00da fond<\/strong><\/td>\nEur\u00f3psky fond region\u00e1lneho rozvoja<\/td>\n<\/tr>\n
V\u00fdzva <\/strong><\/td>\nV\u00fdzva na predkladanie \u017eiadost\u00ed o poskytnutie nen\u00e1vratn\u00e9ho finan\u010dn\u00e9ho pr\u00edspevku na podporu \u00fa\u010dasti slovensk\u00fdch v\u00fdskumn\u00fdch in\u0161tit\u00faci\u00ed v medzin\u00e1rodn\u00fdch v\u00fdskumn\u00fdch projektoch zameran\u00fdch na boj proti pand\u00e9mii vyvolanej ochoren\u00edm COVID-19<\/td>\n<\/tr>\n
K\u00f3d v\u00fdzvy<\/strong><\/td>\nOPII-VA\/DP\/2020\/9.2-01<\/td>\n<\/tr>\n
K\u00f3d projektu v ITMS2014+<\/strong><\/td>\n\u00a0313011AUW7<\/td>\n<\/tr>\n
N\u00e1zov projektu<\/strong><\/td>\nNano\u010dastice pre rie\u0161enie diagnosticko-terapeutick\u00fdch probl\u00e9mov s COVID-19 (NANOVIR)(pdf.plag\u00e1t projektu)<\/em><\/a><\/td>\n<\/tr>\n
Subjekt\/prij\u00edmate\u013e pomoci<\/strong><\/td>\nUniverzita Pavla Jozefa \u0160af\u00e1rika v Ko\u0161iciach<\/td>\n<\/tr>\n
Partner 1<\/strong><\/p>\n

Partner 2<\/strong><\/td>\n

Univerzita veterin\u00e1rneho lek\u00e1rstva a farm\u00e1cie v Ko\u0161iciach<\/p>\n

\u00dastav experiment\u00e1lnej fyziky Slovenskej akad\u00e9mie vied<\/td>\n<\/tr>\n

Financovanie projektu<\/strong><\/td>\nCOV<\/td>\n1 916 0004,79 EUR<\/td>\n<\/tr>\n
NFP<\/td>\n1 842 367,76EUR<\/td>\n<\/tr>\n
VZ<\/td>\n73 637,03 EUR<\/td>\n<\/tr>\n
Obdobie realiz\u00e1cie projektu<\/strong><\/td>\n01\/2021 \u2013 06\/2023<\/td>\n<\/tr>\n
Miesto realiz\u00e1cie projektu<\/strong><\/td>\nSR\/ Ko\u0161ick\u00fd kraj\/ Ko\u0161ice I – mestsk\u00e1 \u010das\u0165 Star\u00e9 Mesto<\/p>\n

SR\/ Ko\u0161ick\u00fd kraj\/ Ko\u0161ice I – mestsk\u00e1 \u010das\u0165 Sever<\/p>\n

SR\/ Ko\u0161ick\u00fd kraj\/ Ko\u0161ice IV – mestsk\u00e1 \u010das\u0165 Juh<\/td>\n<\/tr>\n

Dom\u00e9na inteligentnej \u0161pecializ\u00e1cie<\/strong><\/td>\nZdravie obyvate\u013estva a zdravotn\u00edcke technol\u00f3gie<\/td>\n<\/tr>\n
Hlavn\u00e9 relevantn\u00e9 SK NACE odvetvie<\/strong><\/td>\nQ86 \u2013 Zdravotn\u00edctvo<\/td>\n<\/tr>\n
Funk\u010dn\u00e9 v\u00e4zby
\n<\/strong><\/p>\n
    \n
  • \n

    Produktov\u00e1 l\u00ednia \u010d. 1: Produkty na b\u00e1ze nanotechnol\u00f3gi\u00ed, Hlavn\u00fd trend: Inovat\u00edvne
    \ndiagnostick\u00e9 a terapeutick\u00e9 postupy a produkty personalizovanej \/ prec\u00edznej medic\u00edny<\/p>\n<\/li>\n

  • \n

    Produktov\u00e1 l\u00ednia \u010d. 2: Aplika\u010dn\u00e9 formy liekov a lie\u010div\u00fdch pr\u00edpravkov v kontexte ochoren\u00ed s
    \nnajvy\u0161\u0161ou mierou morbidity a mortality … Hlavn\u00fd trend: Inovat\u00edvne lie\u010div\u00e1, inovat\u00edvne
    \nkozmetick\u00e9 produkty a inovat\u00edvne v\u00fd\u017eivov\u00e9 doplnky.<\/p>\n<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n

Predmet v\u00fdskumu
\n<\/strong><\/p>\n
    \n
  • Zv\u00fd\u0161enie \u00fa\u010dasti slovensk\u00fdch v\u00fdskumn\u00fdch in\u0161tit\u00faci\u00ed v medzin\u00e1rodn\u00fdch v\u00fdskumn\u00fdch projektoch zameran\u00fdch na boj proti pand\u00e9mii vyvolanej ochoren\u00edm COVID-19 formou podpory medzin\u00e1rodnej vedeckej spolupr\u00e1ce.<\/li>\n
  • Predmetom v\u00fdskumu je rie\u0161enie diagnosticko-terapeutick\u00fdch probl\u00e9mov ochorenia COVID-19 s vyu\u017eit\u00edm magnetick\u00fdch nano\u010dast\u00edc.<\/li>\n
  • V diagnostickej \u010dasti sa projekt sa zaober\u00e1 pr\u00edpravou, v\u00fdvojom a laden\u00edm vlastnost\u00ed magnetick\u00fdch nano\u010dast\u00edc pre efekt\u00edvnej\u0161iu izol\u00e1ciu v\u00edrusovej RNA z balastu komplexnej klinickej vzorky.<\/li>\n
  • V terapeutickej \u010dasti je predmetom presk\u00fama\u0165 potenci\u00e1l antiv\u00edrusovej terapie a perspekt\u00edvy pod\u00e1vania antivirot\u00edk s vyu\u017eit\u00edm biokompatibiln\u00fdch syst\u00e9mov na pod\u00e1vanie lie\u010div s pred\u013a\u017een\u00fdm \u00fa\u010dinkom na b\u00e1ze silika nano\u010dast\u00edc.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
V\u00fdstup do praxe
\n<\/strong><\/p>\n
    \n
  • Transfer najnov\u0161\u00edch vedeck\u00fdch poznatkov z\u00edskan\u00fdch v spolupr\u00e1ci so \u0161pi\u010dkov\u00fdmi svetov\u00fdmi pracoviskami do praxe.<\/li>\n
  • Pripraven\u00e9 a testovan\u00e9 nov\u00e9, \u00fa\u010dinnej\u0161ie a selekt\u00edvnej\u0161ie syst\u00e9my na diagnostiku COVID-19 (a potenci\u00e1lne aj in\u00fdch infek\u010dn\u00fdch chor\u00f4b) s efekt\u00edvnej\u0161ou izol\u00e1ciou v\u00edrusov\u00e9ho gen\u00f3mu.<\/li>\n
  • Vyvinut\u00fd postup aj na kontrolu kvality odoberan\u00fdch sterov s vyu\u017eit\u00edm izol\u00e1cie bunkovej DNA a jej detekcie vo vzorke s PCR d\u00f4kazom celul\u00e1rneho g\u00e9nu.<\/li>\n
  • Testovan\u00e9 inovat\u00edvne syst\u00e9my s vyu\u017eit\u00edm pri pod\u00e1van\u00ed lie\u010div, ktor\u00e9 prispej\u00fa k cielenej\u0161iemu a efekt\u00edvnej\u0161iemu dod\u00e1vaniu lie\u010div v organizme, \u010do m\u00f4\u017ee n\u00e1sledne prispie\u0165 k potrebe ni\u017e\u0161ej frekvencie pod\u00e1vania lie\u010div, ich vy\u0161\u0161ej efektivite \u010do m\u00e1 priamy efekt na zdravie, ako aj v\u00fdrazn\u00e9 ekonomick\u00e9 benefity.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    V\u010faka podpore<\/strong> v r\u00e1mci opera\u010dn\u00e9ho programu V\u00fdskum a inov\u00e1cie<\/strong> pre projekt \u201e Nano\u010dastice pre rie\u0161enie diagnosticko-terapeutick\u00fdch probl\u00e9mov s COVID-19 (NANOVIR) <\/strong>\u201c s k\u00f3dom OPII-VA\/DP\/2020\/9.2-01\u00a0 313011AUW7 spolufinancovan\u00fd zo zdrojov\u00a0 Eur\u00f3pskeho fondu region\u00e1lneho rozvoja<\/strong> vznikli nasledovn\u00e9 publik\u00e1cie:<\/p>\n